Clorox Posts a Big Earnings Beat, but Costs Push Its Full-Year Profit View to the Low End

The Clorox Company reported adjusted earnings of $1.55 per share for its fiscal first quarter on Monday, well above the $1.07 consensus estimate.

The Clorox Company makes cleaning and disinfecting products, household goods and lifestyle brands. Its labels include Clorox bleach and wipes, Glad, Pine-Sol and Burt's Bees. The company is based in Oakland, California.

It reported results for the quarter ended September 30, 2026. That is the first quarter of its fiscal 2027 year. The release came after the market close on Monday, November 2.

A clear beat, with two big tailwinds

Analysts expected adjusted earnings of $1.07 per share, the S&P consensus estimate reported by StockStory. Adjusted earnings are a non-GAAP measure, the company's own adjusted figure. That single frame also put the revenue estimate at $1.88 billion.

Reported net sales beat that frame too. Sales rose 33 percent from a year earlier, the release says. The financial statement gives the exact pair: $1.91 billion against $1.43 billion.

On the standard GAAP basis, diluted earnings were $1.39 per share. A year earlier they were $0.65 per share. Net earnings attributable to Clorox were $170 million, against $80 million.

Two tailwinds flatter the growth rates, and the release names both. The GOJO acquisition added about 15 points of the sales growth. GOJO is the hygiene business now operating as Clorox Purell ProCare.

Organic sales rose 18 percent, a non-GAAP company measure. The segment review attributes about 18 points of that rise to one comparison effect. A year ago, retailers drew down inventory built up before a software transition.

That transition was the company's ERP switch. ERP is the enterprise software that runs core company operations. The drawdown depressed the year-ago quarter, so lapping it inflates this quarter's growth.

Adjusted earnings growth carries the same warning. The release says lapping the drawdown was worth about 90 cents in the comparison. Much of the 82 percent adjusted jump therefore laps a weak base.

“We entered this fiscal year focused on steadily improving performance while navigating continued input cost pressures. We made good progress in the first quarter, delivering better-than-expected results through strong execution and timing benefits,” said Chair and CEO Linda Rendle.

Rendle said the cost environment has become more challenging. Higher inflationary pressures are reflected in the updated outlook, she said. She said the company has plans to offset the pressure while still investing behind its brands.

Health and Wellness did the heavy lifting

Health and Wellness net sales were $918 million in the quarter. That is up 62 percent from $565 million a year earlier. The GOJO acquisition contributed about 39 points of that growth.

The segment covers cleaning and professional products. Its organic sales rose 23 percent, again helped by lapping the drawdown. Segment adjusted EBIT rose 69 percent, and adjusted EBIT is a non-GAAP segment measure.

Household net sales were $423 million, up 17 percent from $362 million. The segment sells bags and wraps, cat litter and grilling products. Its adjusted EBIT rose 11 percent.

Lifestyle net sales were $283 million, up 16 percent from $245 million. That segment covers food, water filtration and natural personal care. Its adjusted EBIT rose 58 percent.

International net sales were $281 million, up 11 percent from $253 million. Organic sales there rose 9 percent, on stronger shipments across several regions. The release singles out Latin America, and segment adjusted EBIT rose 63 percent.

Margins moved the other way

Gross margin was 40.4 percent in the quarter, on the GAAP basis. A year earlier it was 41.7 percent. On the company's adjusted basis, gross margin was 40.9 percent.

The decline is 130 basis points. A basis point is one-hundredth of a percentage point. Higher commodity costs were the main pressure the release names.

Higher manufacturing and logistics costs added to the drag. Higher volume and cost savings offset only part of it. Gross profit still rose to $770 million, from $596 million, on the larger sales base.

The GOJO deal itself cost margin. Revaluing the acquired GOJO inventory, the inventory step-up, added about 50 basis points of the decline. That charge is named in the release's margin summary.

Cash told a better story. Year-to-date net cash provided by operations was $143 million. A year earlier it was $93 million, a rise of 54 percent.

Full-year ranges held, profit now seen at the low end

Clorox maintained its full-year sales outlook. Net sales are still expected to rise 13 percent to 14 percent. The GOJO acquisition supplies about 9.5 points of that growth, the outlook says.

Organic sales are still expected to rise about 3.5 percent to 4.5 percent. More than 3.5 points of that is the ERP lap benefit. Strip out the lap, and the guided organic gain is close to flat, on the release's own figures.

The profit ranges were held too, with a softer landing spot. Adjusted earnings are still guided to $5.70 to $6.00 per share. The company now expects results closer to the low end of that range.

GAAP diluted earnings are still guided to $5.41 to $5.71 per share. Gross margin is now expected to be about 41.5 percent for the year. Selling and administrative costs are now expected at about 15.5 percent of sales.

What remains unknown

What remains unknown starts with underlying demand. The release does not separate repeat consumer demand from the ERP lap and the acquisition. Readers cannot tell how much of the 33 percent would survive a clean comparison.

The release also gives no dollar figure for full-year input-cost inflation. It names higher-than-normal inflationary headwinds and negative mix in the margin guide. How large those costs get, and whether pricing offsets them, is unstated.

GOJO integration economics are still thin in the release. It discloses transaction costs and the inventory step-up charge. It does not quantify the acquisition synergies expected this year.

What to watch next

What to watch next starts with second-quarter delivery. Later comparisons get cleaner as the ERP lap fades. The test is whether adjusted earnings track the guided low end, or slip below it.

Then watch gross margin against the full-year guide of about 41.5 percent. First-quarter margin was 40.4 percent, so later quarters must run stronger. That gap is the clearest near-term test in the outlook.

Management scheduled prepared remarks for about 4:15 p.m. Eastern Time on Monday, November 2. It also scheduled a live question-and-answer webcast for 5 p.m. that day. The webcast pairs Rendle with Chief Financial Officer Luc Bellet.